The Cancer Letter

Inside information on cancer research and drug development

In Brief

NPR station broadcasts anniversary program on moonshot

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

On Jan. 12, the first anniversary of the National Cancer Moonshot Initiative, NPR’s largest member station, KQED San Francisco, aired a one-hour program, which is posted here.

Guests included:

  • Matthew Ong, reporter, The Cancer Letter

  • Deborah Mayer, professor, school of nursing and director of cancer survivorship, UNC Lineberger Comprehensive Cancer Center at UNC-Chapel Hill; member, Blue Ribbon Panel for Vice President Biden’s Cancer Moonshot

  • Jan Liphardt, associate professor of bioengineering, Stanford University; co-founder, Cancerbase.org

  • Alan Ashworth, president, UCSF Helen Diller Family Comprehensive Cancer Center; senior vice president for Cancer Services, UCSF Health Professor of Medicine

Table of Contents

YOU MAY BE INTERESTED IN

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations

Artificial intelligence is starting to transform life sciences by accelerating drug discovery and development, optimizing clinical trials, and creating personalized treatments for cancer patients, speakers said at the Sept. 18 unveiling of the American Association for Cancer Research 2024 Cancer Progress Report. 
By McKenzie Prillaman
Table of Contents

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account